Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

35.13
-0.2400-0.68%
Pre-market: 33.66-1.4700-4.18%04:36 EDT
Volume:631.79K
Turnover:22.11M
Market Cap:3.25B
PE:-5.59
High:35.47
Open:34.35
Low:34.29
Close:35.37
Loading ...
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 05, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 14, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report